肾动脉狭窄

Parikh SA, Shishehbor MH, Gray BH, et al. SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv. 2014 Dec 1;84(7):1163-71.全文  摘要

Gornik HL, Persu A, Adlam D, et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med. 2019 Jan 16;24(2):164-89.全文  摘要

Anderson JL, Halperin JL, Albert NM, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Apr 2;127(13):1425-43.全文  摘要

Aboyans V, Ricco JB, Bartelink ME, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018 Mar 1;39(9):763-816.全文  摘要

1. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001 Feb 8;344(6):431-42. 摘要

2. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation. 2006 Mar 21;113(11):e463-654.全文  摘要

3. Haller C, Keim M. Current issues in the diagnosis and management of patients with renal artery stenosis: a cardiologic perspective. Prog Cardiovasc Dis. 2003 Nov-Dec;46(3):271-86. 摘要

4. Chonchol M, Linas S. Diagnosis and management of ischemic nephropathy. Clin J Am Soc Nephrol. 2006 Mar;1(2):172-81.全文  摘要

5. White CJ, Jaff MR, Haskal ZJ, et al. Indications for renal arteriography at the time of coronary arteriography. Circulation. 2006 Oct 24;114(17):1892-5.全文  摘要

6. Parikh SA, Shishehbor MH, Gray BH, et al. SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv. 2014 Dec 1;84(7):1163-71.全文  摘要

7. Kaplan NM. Renovascular hypertension. In: Kaplan NM, ed. Clinical hypertension. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:381-403.

8. Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation. 2005 Aug 30;112(9):1362-74.全文  摘要

9. Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002 Sep;36(3):443-51. 摘要

10. Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis. 2001 Jun;37(6):1184-90. 摘要

11. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004 Apr 29;350(18):1862-71. 摘要

12. Boggs HK, Kiang SC, Magtanong E, et al. Pediatric renal artery stenosis: a 19-year experience in management and outcomes at a tertiary pediatric hospital. Ann Vasc Surg. 2022 Jul;83:35-41. 摘要

13. Eisenhauer AC, White CJ. Endovascular treatment of noncoronary obstructive vascular disease. In: Libby P, Bonow RO, Mann DL, et al., eds. Braunwald's heart disease. 8th ed. Philadelphia, PA: Elsevier Saunders; 2008:1532-5.

14. Gornik HL, Persu A, Adlam D, et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med. 2019 Jan 16;24(2):164-89.全文  摘要

15. Mwipatayi BP, Beningfield SJ, White LE, et al. A review of the current treatment of renal artery stenosis. Eur J Vasc Endovasc Surg. 2005 May;29(5):479-88. 摘要

16. Anderson JL, Halperin JL, Albert NM, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Apr 2;127(13):1425-43.全文  摘要

17. Aboyans V, Ricco JB, Bartelink ME, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018 Mar 1;39(9):763-816.全文  摘要

18. Davenport A, Anker SD, Mebazaa A, et al.; Acute Dialysis Quality Initiative (ADQI) Consensus Group. ADQI 7: the clinical management of the Cardio-Renal syndromes: work group statements from the 7th ADQI consensus conference. Nephrol Dial Transplant. 2010 Jul;25(7):2077-89.全文  摘要

19. Hicks CW, Clark TWI, Cooper CJ, et al. Atherosclerotic renovascular disease: a KDIGO (Kidney Disease: Improving Global Outcomes) controversies conference. Am J Kidney Dis. 2022 Feb;79(2):289-301.全文  摘要

20. Zucchelli PC. Hypertension and atherosclerotic renal artery stenosis: diagnostic approach. J Am Soc Nephrol. 2002 Nov;13 Suppl 3:S184-6.全文  摘要

21. Utsunomiya D, Miyazaki M, Nomitsu Y, et al. Clinical role of non-contrast magnetic resonance angiography for evaluation of renal artery stenosis. Circ J. 2008 Oct;72(10):1627-30.全文  摘要

22. Khoo MM, Deeab D, Gedroyc WM, et al. Renal artery stenosis: comparative assessment by unenhanced renal artery MRA versus contrast-enhanced MRA. Eur Radiol. 2011 Jul;21(7):1470-6. 摘要

23. Angeretti MG, Lumia D, Canì A, et al. Non-enhanced MR angiography of renal arteries: comparison with contrast-enhanced MR angiography. Acta Radiol. 2013 Sep;54(7):749-56. 摘要

24. Caridi JG, Stavropoulos SW, Hawkins IF Jr. CO2 digital subtraction angiography for renal artery angioplasty in high-risk patients. AJR Am J Roentgenol. 1999 Dec;173(6):1551-6.全文  摘要

25. Lorch H, Steinhoff J, Fricke L, et al. CO2 angiography of transplanted kidneys [in German]. Rontgenpraxis. 2003;55(1):26-32. 摘要

26. Liss P, Eklöf H, Hellberg O, et al. Renal effects of CO2 and iodinated contrast media in patients undergoing renovascular intervention: a prospective, randomized study. J Vasc Interv Radiol. 2005 Jan;16(1):57-65. 摘要

27. Gerhard-Herman M, Gardin JM, Jaff M, et al. Guidelines for noninvasive vascular laboratory testing: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med. 2006 Nov;11(3):183-200.全文  摘要

28. Hashimoto J, Ito S. Central pulse pressure and aortic stiffness determine renal hemodynamics: pathophysiological implication for microalbuminuria in hypertension. Hypertension. 2011 Nov;58(5):839-46.全文  摘要

29. O'Neill WC. Renal resistive index: a case of mistaken identity. Hypertension. 2014 Nov;64(5):915-7.全文  摘要

30. Olbricht CJ, Paul K, Prokop M, et al. Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography. Kidney Int. 1995 Oct;48(4):1332-7. 摘要

31. Radermacher J. Resistive index: an ideal test for renovascular disease or ischemic nephropathy? Nat Clin Pract Nephrol. 2006 May;2(5):232-3. 摘要

32. Mangiacapra F, Trana C, Sarno G, et al. Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension. Circ Cardiovasc Interv. 2010 Dec;3(6):537-42.全文  摘要

33. Leesar MA, Varma J, Shapira A, et al. Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. J Am Coll Cardiol. 2009 Jun 23;53(25):2363-71.全文  摘要

34. De Bruyne B, Manoharan G, Pijls NH, et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol. 2006 Nov 7;48(9):1851-5.全文  摘要

35. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998 Sep 12;352(9131):837-53. 摘要

36. Gerstein HC, Miller ME, Byington RP, et al; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2545-59.全文  摘要

37. Patel A, MacMahon S, Chalmers J, et al; The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2560-72.全文  摘要

38. Miyamori I, Yasuhara S, Takeda Y, et al. Effects of converting enzyme inhibition on split renal function in renovascular hypertension. Hypertension. 1986 May;8(5):415-21. 摘要

39. Reams GP, Singh A, Logan KW, et al. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition. J Clin Hypertens. 1987 Jun;3(2):153-63. 摘要

40. Plouin PF, Chatellier G, Darné B, et al; Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Hypertension. 1998 Mar;31(3):823-9.全文  摘要

41. Van Jaarsveld BC, Krijnen P, Pieterman H, et al; Dutch Renal Artery Stenosis Intervention Cooperative Study Group. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. N Engl J Med. 2000 Apr 6;342(14):1007-14.全文  摘要

42. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs. continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. J Hum Hypertens. 1998 May;12(5):329-35. 摘要

43. Krijnen P, van Jaarsveld BC, Deinum J, et al. Which patients with hypertension and atherosclerotic renal artery stenosis benefit from immediate intervention? J Hum Hypertens. 2004 Feb;18(2):91-6. 摘要

44. Bhalla V, Textor SC, Beckman JA, et al. Revascularization for renovascular disease: a scientific statement from the American Heart Association. Hypertension. 2022 Aug;79(8):e128-43.全文  摘要

45. Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014 Jan 2;370(1):13-22. 摘要

46. Cheung CM, Patel A, Shaheen N, et al. The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clin Pract. 2007;107(2):c35-42. 摘要

47. Hanzel G, Balon H, Wong O, et al. Prospective evaluation of aggressive medical therapy for atherosclerotic renal artery stenosis, with renal artery stenting reserved for previously injured heart, brain, or kidney. Am J Cardiol. 2005 Nov 1;96(9):1322-7. 摘要

48. Iwashima Y, Kusunoki H, Taniyama A, et al. Impact of percutaneous transluminal renal angioplasty on autonomic nervous system and natriuresis in hypertensive patients with renal artery stenosis. J Am Heart Assoc. 2022 Mar 15;11(6):e023655.全文  摘要

49. Uder M, Humke U. Endovascular therapy of renal artery stenosis: where do we stand today? Cardiovasc Intervent Radiol. 2005 Mar-Apr;28(2):139-47. 摘要

50. Cadour F, Silhol F, Iline N, et al. Insights from intravascular pressure measurement of renal artery revascularization in patients with fibromuscular dysplasia: The DYSART study. J Vasc Surg. 2022 Mar;75(3):939-49.e1.全文  摘要

51. Balk EM, Raman G, Adam GP, et al. Renal artery stenosis management strategies: an updated comparative effectiveness review. Comparative effectiveness review no. 179. AHRQ publication no. 16-EHC026-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2016.全文  摘要

52. Balk E, Raman G, Chung M, et al. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med. 2006 Dec 19;145(12):901-12.全文  摘要

53. Pierdomenico SD, Pierdomenico AM, Cuccurullo C, et al. Cardiac events in hypertensive patients with renal artery stenosis treated with renal angioplasty or drug therapy: meta-analysis of randomized trials. Am J Hypertens. 2012 Nov;25(11):1209-14. 摘要

54. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am. 1984 Aug;11(3):383-92. 摘要

55. Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992 May;2(11):1608-16. 摘要

56. Franklin SS, Smith RD. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension. Am J Med. 1985 Sep 27;79(3C):14-23. 摘要

57. Tillman DM, Malatino LS, Cumming AM, et al. Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function. J Hypertens Suppl. 1984 Dec;2(2):S93-100. 摘要

58. Alonso A, Lau J, Jaber BL, et al. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis. 2004 Jan;43(1):1-9. 摘要

59. Pannu N, Wiebe N, Tonelli M, et al. Prophylaxis strategies for contrast-induced nephropathy. JAMA. 2006 Jun 21;295(23):2765-79.全文  摘要

60. Pizzolo F, Mansueto G, Minniti S, et al. Renovascular disease: effect of ACE gene deletion polymorphism and endovascular revascularization. J Vasc Surg. 2004 Jan;39(1):140-7. 摘要

61. Rocha-Singh K, Jaff MR, Rosenfield K. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol. 2005 Sep 6;46(5):776-83. 摘要

62. White CJ, Ramee SR, Collins TJ, et al. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol. 1997 Nov 15;30(6):1445-50. 摘要

63. Gill KS, Fowler RC. Atherosclerotic renal arterial stenosis: clinical outcomes of stent placement for hypertension and renal failure. Radiology. 2003 Mar;226(3):821-6. 摘要

64. Dorros G, Jaff M, Mathiak L, et al. Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year followup of 1,058 successful patients. Catheter Cardiovasc Interv. 2002 Feb;55(2):182-8. 摘要

65. van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999 Jan 23;353(9149):282-6. 摘要

66. Gonçalves JA, Amorim JE, Soares Neto MM, et al. Clinical efficacy of percutaneous renal revascularization with stent placement in atherosclerotic renovascular disease. Arq Bras Cardiol. 2007 Jan;88(1):85-90.全文  摘要